Repurposing Atovaquone as a Tumor Hypoxia Modifier: A Window of Opportunity Study in Patients with Resectable Non-small Cell Lung Cancer

Skwarski M., McGowan DR., Belcher E., Di Chiara F., Stavroulias D., Prevo R., Macklin PS., Chauhan J., O'Reilly D., Green M., Ferencz P., Rodriguez-Berriguete G., Flight H., Qi C., Holmes J., Buffa F., McCole M., Bulte D., Macpherson R., Higgins GS.

Type

Conference paper

Publication Date

01/11/2020

Volume

108

Pages

S173 - S173

Permalink